Biggest News Aggregation in the World
📰 Alrn News

Alrn News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alrn. Real-time updates on events, politics, business and more.

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Update

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 40,300 shares, a decline of 16.2% from the January 15th total of 48,100 shares. Currently, 1.0% of the shares of the stock are short sold. Based […]
United States Aileron Therapeutics Company Profile Aileron Therapeutics Inc Sigma Planning Corp Texas Capital Bank Wealth Management Services Inc Renaissance Technologies
Source: wkrb13.com

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 10.5% in September

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) was the target of a significant decline in short interest in September. As of September 30th, there was short interest totalling 8,500 shares, a decline of 10.5% from the September 15th total of 9,500 shares. Based on an average daily volume of 15,700 shares, the days-to-cover ratio […]
United States Aileron Therapeutics Company Profile Envestnet Asset Management Inc Geode Capital Management Aileron Therapeutics Inc Renaissance Technologies
Source: wkrb13.com

Aileron Therapeutics (ALRN) to Release Quarterly Earnings on Monday

Aileron Therapeutics (NASDAQ:ALRN – Get Free Report) is scheduled to issue its quarterly earnings data on Monday, August 14th. Aileron Therapeutics Stock Up 1.7 % Aileron Therapeutics stock opened at $1.73 on Friday. The firm’s fifty day moving average price is $1.79 and its two-hundred day moving average price is $1.72. Aileron Therapeutics has a […]
United States Geode Capital Management Envestnet Asset Management Inc Renaissance Technologies Aileron Therapeutics Inc Aileron Therapeutics

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Sees Significant Decrease in Short Interest

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) saw a large decrease in short interest in the month of July. As of July 15th, there was short interest totalling 11,100 shares, a decrease of 8.3% from the June 30th total of 12,100 shares. Based on an average daily volume of 22,200 shares, the days-to-cover ratio […]
United States Aileron Therapeutics Inc Renaissance Technologies Envestnet Asset Management Inc Geode Capital Management Aileron Therapeutics
Source: wkrb13.com

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 50.8% in May

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totalling 18,100 shares, a decline of 50.8% from the April 30th total of 36,800 shares. Approximately 0.6% of the company’s stock are sold short. Based on an average […]
Aileron Therapeutics Company Profile Geode Capital Management Aileron Therapeutics Inc Envestnet Asset Management Inc Renaissance Technologies Aileron Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Aileron Therapeutics (ALRN) Scheduled to Post Quarterly Earnings on Wednesday

Aileron Therapeutics (NASDAQ:ALRN – Get Rating) will be announcing its earnings results on Wednesday, May 3rd. Aileron Therapeutics Stock Performance Shares of ALRN traded down $0.05 during midday trading on Tuesday, hitting $1.40. 4,918 shares of the company traded hands, compared to its average volume of 48,075. Aileron Therapeutics has a 52 week low of […]
Renaissance Technologies Aileron Therapeutics Company Profile Aileron Therapeutics Inc Aileron Therapeutics Get Rating Aileron Therapeutics Daily

Aileron Therapeutics (ALRN) to Release Quarterly Earnings on Wednesday

Aileron Therapeutics (NASDAQ:ALRN – Get Rating) is scheduled to announce its earnings results on Wednesday, May 3rd. Aileron Therapeutics Stock Performance ALRN stock traded down $0.05 during trading on Tuesday, hitting $1.40. 4,918 shares of the company’s stock traded hands, compared to its average volume of 48,079. Aileron Therapeutics has a 52 week low of […]
Renaissance Technologies Exchange Commission Aileron Therapeutics Inc Aileron Therapeutics Get Rating Aileron Therapeutics Daily
Source: wkrb13.com

Aileron Therapeutics, Inc. (NASDAQ:ALRN) Short Interest Down 27.6% in April

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 25,700 shares, a decrease of 27.6% from the March 31st total of 35,500 shares. Based on an average daily volume of 52,100 shares, the days-to-cover ratio is […]
Aileron Therapeutics Company Profile Aileron Therapeutics Inc Renaissance Technologies Aileron Therapeutics Get Rating Aileron Therapeutics Daily
Source: wkrb13.com

The Sandbox Price Reaches $0.59 (SAND) | Daily Political

Aileron Therapeutics, Inc. (NASDAQ:ALRN – Get Rating) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 25,700 shares, a decline of 27.6% from the March 31st total of 35,500 shares. Based on an average trading volume of 52,100 shares, the short-interest ratio is […]
Renaissance Technologies Aileron Therapeutics Inc Exchange Commission Aileron Therapeutics Company Profile Aileron Therapeutics Get Rating

Head to Head Survey: Agios Pharmaceuticals (NASDAQ:AGIO) and Aileron Therapeutics (NASDAQ:ALRN)

Aileron Therapeutics (NASDAQ:ALRN – Get Rating) and Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, risk, dividends and valuation. Analyst Ratings This is a summary of current ratings […]
United Kingdom Lewis Clayton Cantley Huwm Nash Josepha Yanchik Craigb Thompson Gregoryl Verdine

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science